Sign inGet started

Bahcall Safi R

Insider CIK 1325719 · SNTA President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SNTA SYNTA PHARMACEUTICALS CORP P Buy2013-11-132013-11-1520,000$3.75 $75.0K2,053,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2013-06-282013-07-0110,000$5.03 $50.3K2,033,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2013-06-212013-06-2420,000$4.12 $82.4K2,023,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2013-06-142013-06-1710,000$4.06 $40.6K2,003,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2013-06-062013-06-0610,000$4.04 $40.4K1,993,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2013-03-052013-03-07230,000— $0230,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-12-122012-12-1410,000$8.60 $86.0K2,383,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2012-11-122012-11-1310,000$7.12 $71.2K2,373,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2012-09-132012-09-17100,000— $0100,000SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award2012-07-252012-07-2720,000$6.49 $129.8K2,363,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP P Buy2012-06-292012-07-0210,000$5.34 $53.4K2,343,135SEC↗
SNTA SYNTA PHARMACEUTICALS CORP A Award deriv2012-03-062012-03-08185,000— $0185,000SEC↗